Jung, T. W. Et Al. 2018. Hyperlipidemia-induced hepassocin in the liver contributes to insulin resistance in skeletal muscle. Molecular and Cellular Endocrinology , vol.470 , 26-33.

Jung, T. W., Chung, Y. H., Kim, H., Abd El-Aty, A. M., & Jeong, J. H., (2018). Hyperlipidemia-induced hepassocin in the liver contributes to insulin resistance in skeletal muscle. Molecular and Cellular Endocrinology , vol.470, 26-33.

Jung, Tae Et Al. "Hyperlipidemia-induced hepassocin in the liver contributes to insulin resistance in skeletal muscle," Molecular and Cellular Endocrinology , vol.470, 26-33, 2018

Jung, Tae W. Et Al. "Hyperlipidemia-induced hepassocin in the liver contributes to insulin resistance in skeletal muscle." Molecular and Cellular Endocrinology , vol.470, pp.26-33, 2018

Jung, T. W. Et Al. (2018) . "Hyperlipidemia-induced hepassocin in the liver contributes to insulin resistance in skeletal muscle." Molecular and Cellular Endocrinology , vol.470, pp.26-33.

@article{article, author={Tae Woo Jung Et Al. }, title={Hyperlipidemia-induced hepassocin in the liver contributes to insulin resistance in skeletal muscle}, journal={Molecular and Cellular Endocrinology}, year=2018, pages={26-33} }